One of the more complex issues in making heads or tales of vaccine ingredients is the issue of Aluminum adjuvants. What is an adjuvant? Wikipedia explains it as the following:
In immunology, an adjuvant is an agent that may stimulate the immune system and increase the response to a vaccine, without having any specific antigenic effect in itself.[1] The word “adjuvant” comes from the Latin word adiuvare, meaning to help or aid.[2] “An immunologic adjuvant is defined as any substance that acts to accelerate, prolong, or enhance antigen-specific immune responses when used in combination with specific vaccine antigens.”[3]
Adjuvants are part of what has been whimsically called the dirty little secret of vaccines[4] in the scientific community. This dates from the early days of commercial vaccine manufacture, when significant variations in the effectiveness of different batches of the same vaccine were observed, correctly assumed to be due to contamination of the reaction vessels. However, it was soon found that more scrupulous attention to cleanliness actually seemed to reduce the effectiveness of the vaccines, and that the contaminants – “dirt” – actually enhanced the immune response. There are many known adjuvants in widespread use, including oils, aluminium salts, and virosomes.
Authors Tomljenovic L, Shaw CA published a research paper in 2011 in The US National Library of Medicine National Institute of Health titled Aluminum vaccine adjuvants: are they safe? Below is the abstract from the paper.
Aluminum is an experimentally demonstrated neurotoxin and the most commonly used vaccine adjuvant. Despite almost 90 years of widespread use of aluminum adjuvants, medical science’s understanding about their mechanisms of action is still remarkably poor. There is also a concerning scarcity of data on toxicology and pharmacokinetics of these compounds. In spite of this, the notion that aluminum in vaccines is safe appears to be widely accepted. Experimental research, however, clearly shows that aluminum adjuvants have a potential to induce serious immunological disorders in humans. In particular, aluminum in adjuvant form carries a risk for autoimmunity, long-term brain inflammation and associated neurological complications and may thus have profound and widespread adverse health consequences. In our opinion, the possibility that vaccine benefits may have been overrated and the risk of potential adverse effects underestimated, has not been rigorously evaluated in the medical and scientific community. We hope that the present paper will provide a framework for a much needed and long overdue assessment of this highly contentious medical issue.
To read the full article, go to the the US National Library of Medicine National Institute of Health. In order to gain access to the full article you will need to register to the site, and pay fees to download the full articles.
